Fleming P, et al. - An investigation was carried out of the effects of dupilumab on the rates of skin and other infections in patients with moderate-to-severe atopic dermatitis (AD). A decreased incidence of skin infections and eczema herpeticum appeared to correlate with dupilumab in the study cohort. The mechanism underlying this association remained uncertain. However, it displayed the possibility of causing an improvement in AD severity.